Search research articles
Contact Us
Filters
Showing results (251-260 of 254) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 254 results.
Journal of Cachexia, Sarcopenia and Muscle
|
September 4, 2022
Water T2 could predict functional decline in patients with dysferlinopathy
Ursula Moore, Ericky Caldas de Almeida Araújo, Harmen Reyngoudt, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
March 5, 2019
Towards quality assurance and quality control in untargeted metabolomics studies
Richard D Beger, Warwick B Dunn, Abbas Bandukwala, et al.
Brain : a Journal of Neurology
|
April 15, 2014
Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance
Gerald Pfeffer, Gráinne S Gorman, Helen Griffin, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study
Michael A Postow, Peter D Zang, Sumanta K Pal, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 254) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 254 results.
Journal of Cachexia, Sarcopenia and Muscle
|
September 4, 2022
Water T2 could predict functional decline in patients with dysferlinopathy
Ursula Moore, Ericky Caldas de Almeida Araújo, Harmen Reyngoudt, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
March 5, 2019
Towards quality assurance and quality control in untargeted metabolomics studies
Richard D Beger, Warwick B Dunn, Abbas Bandukwala, et al.
Brain : a Journal of Neurology
|
April 15, 2014
Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance
Gerald Pfeffer, Gráinne S Gorman, Helen Griffin, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study
Michael A Postow, Peter D Zang, Sumanta K Pal, et al.
Page
of 26